I. Pronin*, I. Averin*, N. Kaneva, S. Siuleiman, A.Karmanov*, L. Krasteva, A. Bojinova, K. Papazova, D. Dimitrov, S. Igoshina*

Laboratory of Nanoparticle Science and Technology, Department of General and Inorganic Chemistry, Faculty of Chemistry and Pharmacy, University of Sofia, Sofia 1164, Bulgaria

* Penza State University, Russia

Pharmaceutical drugs photodegradation by nanosized ZnO films

 

1. Introduction

Nanostructured materials offer promising opportunities for improved and tailored properties for application in environmental catalysis due to their unique physicochemical properties, caused by their nanosized dimensions and large surface/volume ratios.

Currently, ZnO semiconductor has stimulated great research interest due to its unique optical and electrical properties (nanolasers, piezoelectric nanogenerators, solar cells, gas sensors, good stability, considerable application in photocatalytic reactions in the process of elimination of water contaminants (dyes, pharmaceutical drugs). Several works report the synthesis and high photocatalytic efficiencies of ZnO nanoparticles, powders and colloids. But for water treatment applications, ZnO thin films are preferred to avoid the separation of the catalyst after the degradation process. Several works have been published in respect to photocatalytic properties of ZnO thin films prepared by different methods - pulsed laser deposition (PLD), chemical vapour deposition (CVD), magnetron sputtering  and sol–gel. The sol–gel method has been receiving high attention since it enables us to develop low-cost and simple deposition procedure to obtain large area high quality ZnO films for technological applications.

This paper describes kinetic studies on the photocatalytic degradation of pharmaceutical drugs (Paracetamol and Chloramphenicol) by ZnO thin films annealed at different temperatures. The semiconductor photocatalysts are prepared vie sol-gel method using dip coating technique. Microstructure, surface morphology and photocatalytic properties of the nanostructure films are explored and discussed.

 

2. Experimental

ZnO thin films were prepared by the sol-gel method from zinc acetate dehydrate (≥99.5 %), 2-methoxyethanol (≥99.5%), monoethanolamine (≥99.0%); all of them from Fluka. Zinc acetate dehydrate was dissolved in a mixture of 2-methoxyethanol and monoethanolamine. The mixture solution was stirred at 60 oC for 1 h to yield a clear and homogeneous solution. After the solution was made 1 day at room temperature (23±2 oC), it was coated on glass substrates (ca. 76 x 26 mm, from ISO-LAB (Germany)), using dip coating technique (0.9 cm/min). Then precursor thin films were heated at 80 °C for 15 min to remove the solvent and organic residuals. The coating and heating process was repeated for 5 times. Then the as-prepared thin films were inserted to a furnace and annealed in ambient atmosphere at several temperatures from 100, 300 and 500 oC for 60 min.

Surface morphology of the thin films deposited on glass substrate was measured by Scanning Electron Microscopy (SEM, JSM-5510 (JEOL)). The crystallization behavior of the ZnO thin films deposited was analyzed by X-ray diffractometer (XRD, Siemens D500 with CuKα radiation within 2θ range 30-70 deg at a step of 0.05 deg 2θ and counting time 2 s/step). The average crystallite sizes were estimated according to the Scherrer’s equation.  

 The pharmaceutical drugs – Paracetamol (C8H9NO2, Actavis) and Chloramphenicol (C11H12Cl2N2O5, Actavis), widely used products, were employed as a representative analgesic and antibiotic to evaluate the photocatalytic activity of ZnO thin films. The experiment was performed in a 150 ml glass reactor, equipped with magnetic stirrer (rotating speed ~ 500 rpm controlled by stroboscope) and UV-lamp (Sylvania BLB, 315-400 nm of emission range, 18 W). The light power density at the sample position was 0,66 mW/cm2 as measured with Research Radiometer of Ealing Electro-optics, Inc.). The distance between the sample and the high pressure mercury lamp was 15 cm. The mineralization of the PCA and CA solutions were measured at intervals of 1h and the total irradiation time is 4 h by UV-VIS absorbance spectroscopy (spectrophotometer Evolution 300 Thermo Scientific, wavelength range from 200 to 400 nm). The extent of photocatalytic degradation could be evaluated by measuring the absorbance of the solutions at 243 and 278 nm. The degradation efficiency of PCA and CA were calculated using the equation:

Degradation%=(C0-C)/C0*100 = (A0-A)/A0*100                           (1),

where C0 represents the initial concentration, Ct represents the concentration after t min reaction, A0 represents the initial absorbance, and At represents the absorbance after t min reaction of the Paracetamol and Chloramphenicol at the characteristic absorption wavelength of 243 and 278 nm.

 

3. Results and discussion

Figure 1a shows the surface morphology of ZnO thin films annealed at 100 oC, with very smooth surface, covered by round grains. Therefore, these films have the lowest activity. The sol-gel films, annealed at 500 oC, are more uniform and show much better adhesion of the layers and the highest density of the film. There is ganglia typical surface structure of the film. The surface morphology of the samples (Fig. 1b) is represented by different ganglia-like hills with typical width of about 1 μm and a height of 5-10 μm.

 



                     

                       (a)                                                                   (b)   

 

Fig. 1. SEM images of ZnO thin films annealed at 100oC (a) and 500oC (b).

 

XRD patterns of the ZnO thin films are presented in Fig. 2. The lack of three characteristic peaks of ZnO (Fig. 2a) shows that at 100 oC temperature the material is still in its hydroxide form of rather amorphous state. The crystallite sizes estimated by the Sherrer,s formula are about 30.0 nm. Increasing the annealing temperature causes a transition from orthogonal in to hexagonal structure, respectively from Zn(OH)2 toward ZnO. The diffraction peaks of the sol-gel films (annealed at 500 oC, Fig. 2b) can be indexed to (100), (002), (101), (102), (110), (103), (200), (112) and (201) diffraction planes at = 31.77o, 34.42o, 36.25o, 47.54o, 56.60o, 62.86o, 66.37o, 67.96o and 69.09o, respectively. The films produced are polycrystalline, showing the wurtzite ZnO hexagonal structure, while there is no evidence for the presence of other phases.

Fig. 2. XRD spectra of ZnO sol-gel films annealed at 100 and 500oC.

 

Photocatalytic tests are carried out for all the thin films. Paracetamol and Chloramphenicol are used as a test contaminant. The initial concentrations of the drugs are 15 and 8 ppm. The pH values ​​are observed during the photocatalytic reactions (PCA – 5.58 ÷ 6.69 and CA – 5.31 ÷ 6.49).

Figure 3 demonstrate the bleaching kinetics of the PCA and CA in aqueous solutions by ZnO films (annealed at 100, 300 and 500oC) under UV-light illumination. It can be seen that the degradation efficiency of the thin films increases with increasing annealing temperature. The experiments show that the decolorization of PCA and CA under UV illumination follows pseudo first-order kinetics expressed by . The slope of logarithmic scale represents linear fits of the experimental data points by the equation.

The films annealed at 300 oC have higher photocatalytic activity (PCA - k= 0.0081 min-1 and CA - k= 0.1024 min-1) than those, prepared at 100 oC (PCA - k= 0.0053 min-1 and CA - k= 0.0149 min-1). As seen from the figure, the films obtained at 500 oC have the highest photocatalytic activity (PCA - k= 0.0362 min-1 and CA - k= 0.1373 min-1). The values of the rate constants are confirmed by rate of degradation of the pharmaceutical products. The degradation is calculated using Eq.1.

Nanostructured ZnO films annealed at 500 oC have a highest photocatalytic efficiency (PCA -12.24% and CA – 39.22% for four hours), while samples obtained at 100 oC have a lowest activity (PCA -1.99% and CA – 5.88%), Figure 3.

 

      

 

(a)                                                               (b)

 

Fig. 3. Photodegradation curves of Paracetamol (a) and Chloramphenicol (b) using ZnO thin films as photocatalysts.

 

 

4. Conclusion

In summary, ZnO thin films are deposited by sol–gel method using dip coating technique. The thin films consist of homogeneous and ganglia-like structures belonging to hexagonal wurtzite structures. The crystallites sizes are increased with rise of the annealing temperatures. The enhanced photocatalytic activity of ZnO thin films might be ascribed to the increase of surface to volume ratio, roughness and mean grain size. The good performance of ZnO thin films indicates that it can be used as a promising photocatalyst for the practical application in photocatalytic decolorization of pharmaceutical products.

 

Acknowledgements: This research is financially supported by projects BG051PO001-3.3.06-0050, FP7 project Beyond Everest and Russian Presidential Program of engineer advanced trading.